Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
European Journal of Cancer (Oxford, England : 1990)|April 1, 1996
N-MYC amplification, loss of heterozygosity on the short arm of chromosome 1 and DNA ploidy in retinoblastomaF Doz, M Peter, G Schleiermacher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 16, 2010
Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC NetworkG G Malouf, P Camparo, S Oudard, et al.
British Journal of Cancer|June 21, 2007
Chromosomal CGH identifies patients with a higher risk of relapse in neuroblastoma without MYCN amplificationG Schleiermacher, J Michon, I Huon, et al.
Pediatric Blood & Cancer|August 24, 2013
Malformations, genetic abnormalities, and Wilms tumorS Dumoucel, M Gauthier-Villars, D Stoppa-Lyonnet, et al.
European Journal of Cancer (Oxford, England : 1990)|July 25, 2013
Clear cell sarcomas of the kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: a report of the SIOP Renal Tumour Study GroupR Furtwängler, S L Gooskens, H van Tinteren, et al.
British Journal of Cancer|June 18, 2014
Treatment and outcome of patients with relapsed clear cell sarcoma of the kidney: a combined SIOP and AIEOP studyS L Gooskens, R Furtwängler, F Spreafico, et al.
British Journal of Cancer|September 15, 2012
Segmental chromosomal alterations have prognostic impact in neuroblastoma: a report from the INRG projectG Schleiermacher, V Mosseri, W B London, et al.
Pageof 3